Foxp3: shades of tolerance.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. CD8Rheumatology and immunology research · 2021
   Review
2. An Interplay Between MRTF-A and the Histone Acetyltransferase TIP60 Mediates Hypoxia-Reoxygenation Induced iNOS Transcription in Macrophages.Frontiers in cell and developmental biology · 2020
   Article
3. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-related disorders: an evolving web of heritable autoimmune diseases.Current opinion in pediatrics · 2013
   Review
4. Modification of the FoxP3 transcription factor principally affects inducible T regulatory cells in a model of experimental autoimmune encephalomyelitis.PloS one · 2013
   Article

Corrections and comments

• Comment on
  An N-terminal mutation of the Foxp3 transcription factor alleviates arthritis but exacerbates diabetes.2012
• Comment on
  Loss of epigenetic modification driven by the Foxp3 transcription factor leads to regulatory T cell insufficiency.2012

Authors and funding

2 authors.

Funding

Abstract